Global Nanomedicine Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1902

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.
Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.
In 2018, the global Nanomedicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nanomedicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicine development in United States, Europe and China.

The key players covered in this study
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences

Market segment by Type, the product can be split into
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Market segment by Application, split into
Segmentation encompasses oncology
Infectious diseases
Cardiology
Orthopedics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nanomedicine status, future forecast, growth opportunity, key market and key players.
To present the Nanomedicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nanomedicine Market Size Growth Rate by Type (2014-2025)
1.4.2 Quantum dots
1.4.3 Nanoparticles
1.4.4 Nanoshells
1.4.5 Nanotubes
1.4.6 Nanodevices
1.5 Market by Application
1.5.1 Global Nanomedicine Market Share by Application (2014-2025)
1.5.2 Segmentation encompasses oncology
1.5.3 Infectious diseases
1.5.4 Cardiology
1.5.5 Orthopedics
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nanomedicine Market Size
2.2 Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions (2014-2025)
2.2.2 Nanomedicine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nanomedicine Market Size by Manufacturers
3.1.1 Global Nanomedicine Revenue by Manufacturers (2014-2019)
3.1.2 Global Nanomedicine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.2 Nanomedicine Key Players Head office and Area Served
3.3 Key Players Nanomedicine Product/Solution/Service
3.4 Date of Enter into Nanomedicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nanomedicine Market Size by Type (2014-2019)
4.2 Global Nanomedicine Market Size by Application (2014-2019)

5 United States
5.1 United States Nanomedicine Market Size (2014-2019)
5.2 Nanomedicine Key Players in United States
5.3 United States Nanomedicine Market Size by Type
5.4 United States Nanomedicine Market Size by Application

6 Europe
6.1 Europe Nanomedicine Market Size (2014-2019)
6.2 Nanomedicine Key Players in Europe
6.3 Europe Nanomedicine Market Size by Type
6.4 Europe Nanomedicine Market Size by Application

7 China
7.1 China Nanomedicine Market Size (2014-2019)
7.2 Nanomedicine Key Players in China
7.3 China Nanomedicine Market Size by Type
7.4 China Nanomedicine Market Size by Application

8 Japan
8.1 Japan Nanomedicine Market Size (2014-2019)
8.2 Nanomedicine Key Players in Japan
8.3 Japan Nanomedicine Market Size by Type
8.4 Japan Nanomedicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nanomedicine Market Size (2014-2019)
9.2 Nanomedicine Key Players in Southeast Asia
9.3 Southeast Asia Nanomedicine Market Size by Type
9.4 Southeast Asia Nanomedicine Market Size by Application

10 India
10.1 India Nanomedicine Market Size (2014-2019)
10.2 Nanomedicine Key Players in India
10.3 India Nanomedicine Market Size by Type
10.4 India Nanomedicine Market Size by Application

11 Central & South America
11.1 Central & South America Nanomedicine Market Size (2014-2019)
11.2 Nanomedicine Key Players in Central & South America
11.3 Central & South America Nanomedicine Market Size by Type
11.4 Central & South America Nanomedicine Market Size by Application

12 International Players Profiles
12.1 Combimatrix
12.1.1 Combimatrix Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nanomedicine Introduction
12.1.4 Combimatrix Revenue in Nanomedicine Business (2014-2019)
12.1.5 Combimatrix Recent Development
12.2 Ablynx
12.2.1 Ablynx Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nanomedicine Introduction
12.2.4 Ablynx Revenue in Nanomedicine Business (2014-2019)
12.2.5 Ablynx Recent Development
12.3 Abraxis Bioscience
12.3.1 Abraxis Bioscience Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nanomedicine Introduction
12.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2014-2019)
12.3.5 Abraxis Bioscience Recent Development
12.4 Celgene
12.4.1 Celgene Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nanomedicine Introduction
12.4.4 Celgene Revenue in Nanomedicine Business (2014-2019)
12.4.5 Celgene Recent Development
12.5 Mallinckrodt
12.5.1 Mallinckrodt Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nanomedicine Introduction
12.5.4 Mallinckrodt Revenue in Nanomedicine Business (2014-2019)
12.5.5 Mallinckrodt Recent Development
12.6 Arrowhead Research
12.6.1 Arrowhead Research Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nanomedicine Introduction
12.6.4 Arrowhead Research Revenue in Nanomedicine Business (2014-2019)
12.6.5 Arrowhead Research Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nanomedicine Introduction
12.7.4 GE Healthcare Revenue in Nanomedicine Business (2014-2019)
12.7.5 GE Healthcare Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nanomedicine Introduction
12.8.4 Merck Revenue in Nanomedicine Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nanomedicine Introduction
12.9.4 Pfizer Revenue in Nanomedicine Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Nanosphere
12.10.1 Nanosphere Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nanomedicine Introduction
12.10.4 Nanosphere Revenue in Nanomedicine Business (2014-2019)
12.10.5 Nanosphere Recent Development
12.11 Epeius Biotechnologies
12.12 Cytimmune Sciences
12.13 Nanospectra Biosciences

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details